Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MEDIFAST INC Common Stock (NY:MED)

12.05 -0.02 (-0.17%)
Streaming Delayed Price Updated: 1:35 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Medifast (MED) Q1 2026 Earnings Transcript ↗
Medifast (MED) Q1 2026 Earnings Transcript 
Via The Motley Fool
Medifast (NYSE:MED) Q1 Loss Narrower Than Feared as Coach Productivity Improves ↗
Via Chartmill
News headline image
Medifast (NYSE:MED) Delivers Impressive Q1 CY2026
Wellness company Medifast (NYSE:MED) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 34.3% year on year to $76.04 m... 
Via StockStory
News headline image
Medifast (MED) Q1 Earnings: What To Expect
Wellness company Medifast (NYSE:MED) will be reporting earnings this Monday afternoon. Here’s what to expect. Medifast beat analysts’ revenue expectations la... 
Via StockStory
Topics Artificial Intelligence
Medifast Inc (NYSE:MED) Reports Mixed Q4 Results with Deepening Losses and Challenging 2026 Outlook ↗
Via Chartmill
News headline image
3 Unprofitable Stocks Walking a Fine Line
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding... 
Via StockStory
News headline image
Personal Care Stocks Q4 In Review: Coty (NYSE:COTY) Vs Peers
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Coty (NYSE:COTY) and its pe... 
Via StockStory
Topics Economy
News headline image
3 Consumer Stocks That Concern Us
Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. Surprisingly, the sector hasn’t played its shielding role over t... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We Steer Clear Of
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
3 Reasons MED is Risky and 1 Stock to Buy Instead
What a brutal six months it’s been for Medifast. The stock has dropped 27.7% and now trades at $9.88, rattling many shareholders. This was partly driven by i... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Small-Cap Stock with Exciting Potential and 2 We Find Risky
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
News headline image
Winners And Losers Of Q4: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the personal care stocks, including Medifast (NYSE:MED) and its peers. While personal c... 
Via StockStory
Topics Economy
News headline image
3 Out-of-Favor Stocks with Open Questions
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet... 
Via StockStory
News headline image
Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions
Medifast’s fourth quarter results outperformed Wall Street’s revenue expectations, which the market responded to positively. Management attributed this to early signs of success from its transition to... 
Via StockStory
Topics Earnings
News headline image
MED Q4 Deep Dive: Metabolic Health Pivot Drives Early Coach Productivity Gains
Wellness company Medifast (NYSE:MED) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 36.9% year on year to $75.1 million. On the other hand, next quarter’s revenue... 
Via StockStory
News headline image
Medifast (MED) Q4 2025 Earnings Call Transcript ↗
Medifast (MED) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Medifast’s (NYSE:MED) Q4 CY2025 Sales Top Estimates
Wellness company Medifast (NYSE:MED) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 36.9% year on year to $75.1 million. On the other hand, next quarter’s... 
Via StockStory
News headline image
Earnings To Watch: Medifast (MED) Reports Q4 Results Tomorrow
Wellness company Medifast (NYSE:MED) will be reporting results this Tuesday after the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Stocks Under $50 We Approach with Caution
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
3 Reasons to Avoid MED and 1 Stock to Buy Instead
Over the past six months, Medifast’s stock price fell to $11.62. Shareholders have lost 18.9% of their capital, which is disappointing considering the S&P 500 has climbed by 11.3%. This might have... 
Via StockStory
Topics Stocks
News headline image
1 Consumer Stock to Target This Week and 2 We Question
Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. But they’re also double-edged swords as they often lag in booming conditions, and this pattern has persisted... 
Via StockStory
Topics Stocks
News headline image
Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Medifast (NYSE:MED) and its peers. 
Via StockStory
Topics Economy
News headline image
3 Stocks Under $50 We’re Skeptical Of
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
News headline image
3 Small-Cap Stocks That Fall Short
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
3 Unprofitable Stocks That Fall Short
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
News headline image
5 Insightful Analyst Questions From Medifast’s Q3 Earnings Call
Medifast’s third quarter results met Wall Street’s revenue expectations, but the market responded negatively as sales continued to decline sharply year-over-year. Management attributed these results to... 
Via StockStory
Topics Earnings
News headline image
MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges
Wellness company Medifast (NYSE:MED) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 36.2% year on year to $89.41 million. On the other hand, next quarter’s revenue guidance of... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.